Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2015-04-29 | He received his medical degree and board certifications from the University of Pavia in Italy. |
2016-06-21 | Dr. Taglietti received his medical degree and board certifications from the University of Pavia in Italy. He has held executive roles in pharmaceutical companies but no mention of software or programming skills. |
2017-05-05 | Dr. Marco Taglietti, M.D. was appointed as a Director in December 2014... He received his medical degree and board certifications from the University of Pavia in Italy. |
2017-07-26 | Marco Taglietti, M.D. is listed as a director with no software-related skills mentioned. |
2018-02-26 | Marco Taglietti, M.D. is listed as a director with no mention of software or technical background. |
2019-08-19 | Dr. Marco Taglietti, M.D. was appointed as a director in December 2014. Dr. Taglietti serves as CEO and on the Board of Directors of NASDAQ-listed SCYNEXIS, Inc., a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives. ... He received his medical degree and board certifications from the University of Pavia in Italy. |
Data sourced from SEC filings. Last updated: 2025-08-30